Erythema
Showing 1 - 25 of 44
Erythema, Radiation Therapy, Secondary Skin Reactions Trial in Fort Myers (VS-200Cr, Standard of care)
Not yet recruiting
- Erythema
- Radiation Therapy, Secondary Skin Reactions
- VS-200Cr
- Standard of care
-
Fort Myers, FloridaAdvocate Radiation Oncology
Aug 23, 2023
Erythema, Maceration, Lesion Skin Trial in Lincoln (DriGo Skin Protectant Textile)
Enrolling by invitation
- Erythema
- +3 more
- DriGo Skin Protectant Textile
-
Lincoln, NebraskaBryan Medical Center
Feb 20, 2023
Acne Vulgaris, Post Inflammatory Hyperpigmentation, Post Inflammatory Pigmentation Change Trial in Boston (Tazarotene 0.045%
Completed
- Acne Vulgaris
- +4 more
- Tazarotene 0.045% Lotion
-
Boston, MassachusettsThe Dermatology Institute of Boston
Jan 19, 2023
Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Edema
- +8 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2023
Erythema, Rosacea Trial in United States (CD07805/47 gel 0.5%/CD07805/47 Vehicle, azelaic acid gel 15%)
Completed
- Erythema
- Rosacea
- CD07805/47 gel 0.5%/CD07805/47 Vehicle
- azelaic acid gel 15%
-
Evansville, Indiana
- +3 more
Jul 28, 2022
Erythema, Sun Damaged Skin, Skin Inflammation Trial in Schenefeld (Topical Placebo Cream, Topical Cream with 0.5% Active,
Completed
- Erythema
- +2 more
- Topical Placebo Cream
- +2 more
-
Schenefeld, Germanyproderm GmbH
Apr 13, 2022
MS (Multiple Sclerosis), Erythema Trial in Kirkland (Warm Compress Before Injection, Cold Compress After Injection)
Completed
- MS (Multiple Sclerosis)
- Erythema
- Warm Compress Before Injection
- Cold Compress After Injection
-
Kirkland, WashingtonEvergreen Health
Mar 10, 2022
Erythema Trial in Boston (DuraporeTM and Hy-Tape®)
Completed
- Erythema
- DuraporeTM and Hy-Tape®
-
Boston, MassachusettsTufts Medical Center
Sep 7, 2021
Rosacea, Erythema Trial in Germany, Sweden, United Kingdom (Brimonidine tartrate was applied cutaneously once daily for 8 days.,
Completed
- Rosacea
- Erythema
- Brimonidine tartrate was applied cutaneously once daily for 8 days.
- Brimonidine tartrate vehicle was applied cutaneously once daily for 8 days.
-
Berlin, Germany
- +13 more
Aug 23, 2021
Erythema Trial (MED Test, Wearing device)
Not yet recruiting
- Erythema
- MED Test
- Wearing device
- (no location specified)
Jul 15, 2021
Erythema, Inflammation Trial in Los Angeles (Pomegranate Juice, Placebo Juice)
Terminated
- Erythema
- Inflammation
- Pomegranate Juice
- Placebo Juice
-
Los Angeles, CaliforniaUCLA Center for Human Nutriiton
Apr 14, 2021
Erythema, Edema Trial in Union ("Chameleon" Personal Lubricant)
Completed
- Erythema
- Edema
- "Chameleon" Personal Lubricant
-
Union, New JerseyHarrison Research Laboratories, Inc.
Mar 24, 2021
Transepidermal Water Loss, Erythema Trial in Chelmsford (Test Article)
Completed
- Transepidermal Water Loss
- Erythema
- Test Article
-
Chelmsford, Essex, United KingdomPrinceton Research Corporation
Aug 11, 2020
Erythema, Sensitisation Trial in New City (CB-0002B)
Completed
- Erythema
- Sensitisation
- CB-0002B
-
New City, New YorkAMA Laboratories Inc.
Jul 31, 2020
Erythema, Skin Recovery Trial in Sao Paulo (BAY207543 (Bepanthol), Semisolid vaseline)
Completed
- Erythema
- Skin Recovery
- BAY207543 (Bepanthol)
- Semisolid vaseline
-
Sao Paulo, BrazilMedcin Instituto da Pele
Apr 16, 2020
Erythema, Skin Recovery Trial in Sao Paulo (BAY207543 (Bepanthol, Bepantol® Derma Spray), Semisolid vaseline)
Completed
- Erythema
- Skin Recovery
- BAY207543 (Bepanthol, Bepantol® Derma Spray)
- Semisolid vaseline
-
Sao Paulo, BrazilMedcin Instituto da Pele
Mar 5, 2020
Erythema Trial (50/100, 100/50)
Completed
- Erythema
- 50/100
- 100/50
- (no location specified)
Dec 16, 2019
Erythema, Rosacea Trial in College Station (Oxymetazoline HCL Cream 1.0%, Vehicle to Oxymetazoline HCL Cream)
Completed
- Erythema
- Rosacea
- Oxymetazoline HCL Cream 1.0%
- Vehicle to Oxymetazoline HCL Cream
-
College Station, Texas(unnamed)
Nov 15, 2019
Erythema, Rosacea Trial in Lynchburg (AGN-199201, Vehicle to AGN-199201)
Completed
- Erythema
- Rosacea
- AGN-199201
- Vehicle to AGN-199201
-
Lynchburg, Virginia(unnamed)
Nov 15, 2019
Rosacea, Erythema Trial in Austin (AGN-199201 Dose A, AGN-199201 Dose B, AGN-199201 Dose C)
Completed
- Rosacea
- Erythema
- AGN-199201 Dose A
- +3 more
-
Austin, Texas(unnamed)
Nov 15, 2019
Erythema, Rosacea Trial in Portland (Oxymetazoline HCL Cream 1.0%)
Completed
- Erythema
- Rosacea
- Oxymetazoline HCL Cream 1.0%
-
Portland, Oregon(unnamed)
Nov 15, 2019
Rosacea, Erythema Trial in Austin (AGN-199201 Formulation A, AGN-199201 Formulation B, AGN-199201 Formulation C)
Completed
- Rosacea
- Erythema
- AGN-199201 Formulation A
- +3 more
-
Austin, Texas(unnamed)
Nov 15, 2019
Erythema Trial in Boston (Medical tapes: TegadermTM and EyeGard®)
Completed
- Erythema
- Medical tapes: TegadermTM and EyeGard®
-
Boston, MassachusettsTufts Medical Center
Aug 20, 2019